Menu
Currency
GWAS Study

Genome-wide association study identifies three new melanoma susceptibility loci.

Barrett JH, Iles MM, Harland M et al.

21983787 PubMed ID
GWAS Study Type
23422 Participants
55 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

BJ
Barrett JH
IM
Iles MM
HM
Harland M
TJ
Taylor JC
AJ
Aitken JF
AP
Andresen PA
AL
Akslen LA
AB
Armstrong BK
AM
Avril MF
AE
Azizi E
BB
Bakker B
BW
Bergman W
BG
Bianchi-Scarrà G
BP
Bressac-de Paillerets B
CD
Calista D
CL
Cannon-Albright LA
CE
Corda E
CA
Cust AE
DT
Dębniak T
DD
Duffy D
DA
Dunning AM
ED
Easton DF
FE
Friedman E
GP
Galan P
GP
Ghiorzo P
GG
Giles GG
HJ
Hansson J
HM
Hocevar M
HV
Höiom V
HJ
Hopper JL
IC
Ingvar C
JB
Janssen B
JM
Jenkins MA
JG
Jönsson G
KR
Kefford RF
LG
Landi G
LM
Landi MT
LJ
Lang J
LJ
Lubiński J
MR
Mackie R
MJ
Malvehy J
MN
Martin NG
MA
Molven A
MG
Montgomery GW
VN
van Nieuwpoort FA
NS
Novakovic S
OH
Olsson H
PL
Pastorino L
PS
Puig S
PJ
Puig-Butille JA
RJ
Randerson-Moor J
SH
Snowden H
TR
Tuominen R
VB
Van Belle P
VD
van der Stoep N
WD
Whiteman DC
ZD
Zelenika D
HJ
Han J
FS
Fang S
LJ
Lee JE
WQ
Wei Q
LG
Lathrop GM
GE
Gillanders EM
BK
Brown KM
GA
Goldstein AM
KP
Kanetsky PA
MG
Mann GJ
MS
Macgregor S
ED
Elder DE
AC
Amos CI
HN
Hayward NK
GN
Gruis NA
DF
Demenais F
BJ
Bishop JA
BD
Bishop DT
Chapter II

Abstract

Summary of the research findings

We report a genome-wide association study for melanoma that was conducted by the GenoMEL Consortium. Our discovery phase included 2,981 individuals with melanoma and 1,982 study-specific control individuals of European ancestry, as well as an additional 6,426 control subjects from French or British populations, all of whom were genotyped for 317,000 or 610,000 single-nucleotide polymorphisms (SNPs). Our analysis replicated previously known melanoma susceptibility loci. Seven new regions with at least one SNP with P < 10(-5) and further local imputed or genotyped support were selected for replication using two other genome-wide studies (from Australia and Texas, USA). Additional replication came from case-control series from the UK and The Netherlands. Variants at three of the seven loci replicated at P < 10(-3): an SNP in ATM (rs1801516, overall P = 3.4 × 10(-9)), an SNP in MX2 (rs45430, P = 2.9 × 10(-9)) and an SNP adjacent to CASP8 (rs13016963, P = 8.6 × 10(-10)). A fourth locus near CCND1 remains of potential interest, showing suggestive but inconclusive evidence of replication (rs1485993, overall P = 4.6 × 10(-7) under a fixed-effects model and P = 1.2 × 10(-3) under a random-effects model). These newly associated variants showed no association with nevus or pigmentation phenotypes in a large British case-control series.

2,804 European ancestry cases, 7,618 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

23422
Total Participants
GWAS
Study Type
Yes
Replicated
5,551 European ancestry cases, 7,449 European ancestry controls
Replication Participants
European
Ancestry
Sweden, U.S., Poland, Israel, Australia, Italy, Netherlands, U.K., Spain, France, Norway
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.